WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹1.91 Cr | ₹-21 Cr | ₹13 Cr | ₹7.34 Cr | ₹-0.08 Cr |
What is the latest Net Cash Inflow / Outflow ratio of WANBURY ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹1.91 Cr |
Mar2023 | ₹-21 Cr |
Mar2022 | ₹13 Cr |
Mar2021 | ₹7.34 Cr |
Mar2020 | ₹-0.08 Cr |
How is Net Cash Inflow / Outflow of WANBURY Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹1.91 Cr | Positive | |
Mar2023 | ₹-21 Cr | Negative | |
Mar2022 | ₹13 Cr | 70.64 | |
Mar2021 | ₹7.34 Cr | Positive | |
Mar2020 | ₹-0.08 Cr | - |
Compare Net Cash Inflow / Outflow of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹689.5 Cr | 4.8% | -1.7% | 37.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,012.0 Cr | 4.6% | -0.9% | 5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,188.0 Cr | 0.5% | -5.5% | 57.2% | Stock Analytics | |
CIPLA | ₹118,041.0 Cr | 0.2% | 0.6% | -3.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,512.0 Cr | -0.4% | -1.5% | 14.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,445.1 Cr | -2.2% | -8.6% | -13.4% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | 4.8% |
-1.7% |
37.8% |
SENSEX | -0.7% |
-4.5% |
-0.4% |
You may also like the below Video Courses